172 related articles for article (PubMed ID: 30791598)
1. Augmentation of Saporin-Based Immunotoxins for Human Leukaemia and Lymphoma Cells by Triterpenoid Saponins: The Modifying Effects of Small Molecule Pharmacological Agents.
Smith WS; Johnston DA; Holmes SE; Wensley HJ; Flavell SU; Flavell DJ
Toxins (Basel); 2019 Feb; 11(2):. PubMed ID: 30791598
[TBL] [Abstract][Full Text] [Related]
2. The Role of Cholesterol on Triterpenoid Saponin-Induced Endolysosomal Escape of a Saporin-Based Immunotoxin.
Smith WS; Johnston DA; Wensley HJ; Holmes SE; Flavell SU; Flavell DJ
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228031
[TBL] [Abstract][Full Text] [Related]
3. Triterpenoid saponin augmention of saporin-based immunotoxin cytotoxicity for human leukaemia and lymphoma cells is partially immunospecific and target molecule dependent.
Holmes SE; Bachran C; Fuchs H; Weng A; Melzig MF; Flavell SU; Flavell DJ
Immunopharmacol Immunotoxicol; 2015 Feb; 37(1):42-55. PubMed ID: 25347443
[TBL] [Abstract][Full Text] [Related]
4. Membrane cholesterol is essential for triterpenoid saponin augmentation of a saporin-based immunotoxin directed against CD19 on human lymphoma cells.
Smith WS; Baker EJ; Holmes SE; Koster G; Hunt AN; Johnston DA; Flavell SU; Flavell DJ
Biochim Biophys Acta Biomembr; 2017 May; 1859(5):993-1007. PubMed ID: 28235471
[TBL] [Abstract][Full Text] [Related]
5. The Effect of Small Molecule Pharmacological Agents on the Triterpenoid Saponin Induced Endolysosomal Escape of Saporin and a Saporin-Based Immunotoxin in Target Human Lymphoma Cells.
Wensley HJ; Smith WS; Holmes SE; Flavell SU; Flavell DJ
Biomedicines; 2021 Mar; 9(3):. PubMed ID: 33804080
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the performance of anti-CD7 and anti-CD38 bispecific antibodies and immunotoxins for the delivery of saporin to a human T-cell acute lymphoblastic leukemia cell line.
Flavell DJ; Cooper S; Okayama K; Emery L; Flavell SU
Hematol Oncol; 1995; 13(4):185-200. PubMed ID: 7557895
[TBL] [Abstract][Full Text] [Related]
7. The saponin-mediated enhanced uptake of targeted saporin-based drugs is strongly dependent on the saponin structure.
Bachran C; Sutherland M; Heisler I; Hebestreit P; Melzig MF; Fuchs H
Exp Biol Med (Maywood); 2006 Apr; 231(4):412-20. PubMed ID: 16565437
[TBL] [Abstract][Full Text] [Related]
8. Preclinical studies with the anti-CD19-saporin immunotoxin BU12-SAPORIN for the treatment of human-B-cell tumours.
Flavell DJ; Flavell SU; Boehm DA; Emery L; Noss A; Ling NR; Richardson PR; Hardie D; Wright DH
Br J Cancer; 1995 Dec; 72(6):1373-9. PubMed ID: 8519647
[TBL] [Abstract][Full Text] [Related]
9. A Flow Cytometric Method to Quantify the Endosomal Escape of a Protein Toxin to the Cytosol of Target Cells.
Wensley HJ; Johnston DA; Smith WS; Holmes SE; Flavell SU; Flavell DJ
Pharm Res; 2019 Dec; 37(1):16. PubMed ID: 31873810
[TBL] [Abstract][Full Text] [Related]
10. Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual immunotoxin.
Flavell DJ; Boehm DA; Noss A; Warnes SL; Flavell SU
Br J Cancer; 2001 Feb; 84(4):571-8. PubMed ID: 11207056
[TBL] [Abstract][Full Text] [Related]
11. Therapy of human B-cell lymphoma bearing SCID mice is more effective with anti-CD19- and anti-CD38-saporin immunotoxins used in combination than with either immunotoxin used alone.
Flavell DJ; Boehm DA; Emery L; Noss A; Ramsay A; Flavell SU
Int J Cancer; 1995 Jul; 62(3):337-44. PubMed ID: 7543082
[TBL] [Abstract][Full Text] [Related]
12. Soapwort saponins trigger clathrin-mediated endocytosis of saporin, a type I ribosome-inactivating protein.
Weng A; Bachran C; Fuchs H; Melzig MF
Chem Biol Interact; 2008 Nov; 176(2-3):204-11. PubMed ID: 18775419
[TBL] [Abstract][Full Text] [Related]
13. Saponins from Saponaria officinalis L. Augment the Efficacy of a Rituximab-Immunotoxin.
Gilabert-Oriol R; Thakur M; Haussmann K; Niesler N; Bhargava C; Görick C; Fuchs H; Weng A
Planta Med; 2016 Dec; 82(18):1525-1531. PubMed ID: 27392242
[TBL] [Abstract][Full Text] [Related]
14. Liquid-chromatographic profiling of Saponinum album (Merck).
Weng A; Thakur M; Schindler A; Fuchs H; Melzig MF
Pharmazie; 2011 Oct; 66(10):744-6. PubMed ID: 22026154
[TBL] [Abstract][Full Text] [Related]
15. The endocytic uptake pathways of targeted toxins are influenced by synergistically acting Gypsophila saponins.
Bachran D; Schneider S; Bachran C; Weng A; Melzig MF; Fuchs H
Mol Pharm; 2011 Dec; 8(6):2262-72. PubMed ID: 21981719
[TBL] [Abstract][Full Text] [Related]
16. The anti-CD20 antibody rituximab augments the immunospecific therapeutic effectiveness of an anti-CD19 immunotoxin directed against human B-cell lymphoma.
Flavell DJ; Warnes SL; Bryson CJ; Field SA; Noss AL; Packham G; Flavell SU
Br J Haematol; 2006 Jul; 134(2):157-70. PubMed ID: 16771848
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of combinations of bispecific antibodies for delivering saporin to human acute T-cell lymphoblastic leukaemia cell lines via CD7 and CD38 as cellular target molecules.
Flavell DJ; Cooper S; Morland B; French R; Flavell SU
Br J Cancer; 1992 Apr; 65(4):545-51. PubMed ID: 1373293
[TBL] [Abstract][Full Text] [Related]
18. Characteristics and performance of a bispecific F (ab'gamma)2 antibody for delivering saporin to a CD7+ human acute T-cell leukaemia cell line.
Flavell DJ; Cooper S; Morland B; Flavell SU
Br J Cancer; 1991 Aug; 64(2):274-80. PubMed ID: 1716453
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the potency and therapeutic efficacy of the anti-CD7 immunotoxin HB2-saporin constructed with one or two saporin moieties per immunotoxin molecule.
Flavell DJ; Boehm DA; Noss A; Flavell SU
Br J Cancer; 1997; 75(7):1035-43. PubMed ID: 9083340
[TBL] [Abstract][Full Text] [Related]
20. Therapy of human T-cell acute lymphoblastic leukaemia in severe combined immunodeficient mice with two different anti-CD7-saporin immunotoxins containing hindered or non-hindered disulphide cross-linkers.
Flavell DJ; Boehm DA; Okayama K; Kohler JA; Flavell SU
Int J Cancer; 1994 Aug; 58(3):407-14. PubMed ID: 7519586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
